Cognitive profiling in relation to short latency afferent inhibition of frontal cortex in multiple system atrophy

Parkinsonism and Related Disorders

Volumn 20, Issue 6, 2014, Pages 632-636

  Celebi, Ozlem ^a   Temuçin, Çaǧri Mesut ^a   Elibol, Bulent ^a   Saka, Esen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cognitive functions; Multiple system atrophy; Parkinson's disease; Short latency afferent inhibition; Transcranial magnetic stimulation

Indexed keywords

ADULT; AGED; ARTICLE; ATTENTION; BRAIN ELECTROPHYSIOLOGY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEPTH PERCEPTION; DISEASE DURATION; EXECUTIVE FUNCTION; FEMALE; FRONTAL CORTEX; HUMAN; LATENT PERIOD; MALE; MEMORY; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SHORT LATENCY AFFERENT INHIBITION; SHY DRAGER SYNDROME; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; COGNITION DISORDERS; COMPLICATION; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EVOKED MUSCLE RESPONSE; FRONTAL LOBE; MENTAL HEALTH; MIDDLE AGED; NERVE CELL INHIBITION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REACTION TIME; TRANSCRANIAL MAGNETIC STIMULATION;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; FRONTAL LOBE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEURAL INHIBITION; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84900000039     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.03.012     Document Type: Article

References (30)

1. Gilman S., Wenning G.K., Low P.A., Brooks D.J., Mathias C.J., Trojanowski J.Q., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
2. Gilman S., Low P.A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C.J., et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999, 163:94-98.
3. Dujardin K., Defebvre L., Krystkowiak P., Degreef J.F., Destee A. Executive function differences in multiple system atrophy and Parkinson's disease. Parkinsonism Relat Disord 2003, 9:205-211.
4. Brown R.G., Lacomblez L., Landwehrmeyer B.G., Bak T., Uttner I., Dubois B., et al. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 2010, 133:2382-2393.
5. Kawai Y., Suenaga M., Takeda A., Ito M., Watanabe H., Tanaka F., et al. Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P. Neurology 2008, 70:1390-1396.
6. Siri C., Duerr S., Canesi M., Delazer M., Esselink R., Bloem B.R., et al. A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type. J Neural Transm 2013, 120:613-618.
7. Di Lazzaro V., Oliviero A., Profice P., Pennisi M.A., Di Giovanni S., Zito G., et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 2000, 135:455-461.
8. Di Lazzaro V., Pilato F., Dileone M., Profice P., Ranieri F., Ricci V., et al. Segregating two inhibitory circuits in human motor cortex at the level of GABAA receptor subtypes: a TMS study. Clin Neurophysiol 2007, 118:2207-2214.
9. Sailer A., Molnar G.F., Paradiso G., Gunraj C.A., Lang A.E., Chen R. Short and long latency afferent inhibition in Parkinson's disease. Brain 2003, 126:1883-1894.
10. Celebi O., Temucin C.M., Elibol B., Saka E. Short latency afferent inhibition in Parkinson's disease patients with dementia. Mov Disord 2012, 27:1052-1055.
11. Yarnall A.J., Rochester L., Baker M.R., David R., Khoo T.K., Duncan G.W., et al. Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease?. Mov Disord 2013, 28:1285-1288.
12. Gilman S., Koeppe R.A., Nan B., Wang C.N., Wang X., Junck L., et al. Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology 2010, 74:1416-1423.
13. Wenning G.K., Tison F., Seppi K., Sampaio C., Diem A., Yekhlef F., et al. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 2004, 19:1391-1402.
14. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010, 25:2649-2653.
15. Nielsen J.E., Jennum P., Fenger K., Sorensen S.A., Fuglsang-Frederiksen A. Increased intracortical facilitation in patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p. Eur J Neurol 2001, 8:335-339.
16. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
17. Saka E., Elibol B. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction. Parkinsonism Relat Disord 2009, 15:688-691.
18. Cangoz B., Karakoc E., Selekler K. Trail Making Test: normative data for Turkish elderly population by age, sex and education. J Neurol Sci 2009, 283:73-78.
19. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M., et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982, 17:37-49.
20. Lee W., Williams D.R., Storey E. Cognitive testing in the diagnosis of parkinsonian disorders: a critical appraisal of the literature. Mov Disord 2012, 27:1243-1254.
21. Kawamura K., Shimohata T., Nakayama H., Tomita M., Ozawa T., Nishizawa M. Factors influencing the cognitive function in patients with multiple system atrophy. Mov Disord 2010, 25:2891-2892.
22. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
23. Nardone R., Bergmann J., Christova M., Caleri F., Tezzon F., Ladurner G., et al. Short latency afferent inhibition differs among the subtypes of mild cognitive impairment. J Neural Transm 2012, 119:463-471.
24. Halliday G.M., Holton J.L., Revesz T., Dickson D.W. Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol 2011, 122:187-204.
25. Konagaya M., Sakai M., Matsuoka Y., Konagaya Y., Hashizume Y. Multiple system atrophy with remarkable frontal lobe atrophy. Acta Neuropathol 1999, 97:423-428.
26. Wakabayashi K., Ikeuchi T., Ishikawa A., Takahashi H. Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter. J Neurol Sci 1998, 156:114-117.
27. Otsuka M., Ichiya Y., Kuwabara Y., Hosokawa S., Sasaki M., Yoshida T., et al. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study. J Neurol Sci 1996, 144:77-83.
28. Paviour D.C., Price S.L., Jahanshahi M., Lees A.J., Fox N.C. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006, 21:989-996.
29. Schmahmann J.D., Sherman J.C. The cerebellar cognitive affective syndrome. Brain 1998, 121(Pt 4):561-579.
30. Middleton F.A., Strick P.L. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Brain Res Rev 2000, 31:236-250.